QAB149
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for QAB149, covering 2011-10-25 to 2016-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation [Phase 3]